SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001062993-23-020477
Filing Date
2023-11-13
Accepted
2023-11-13 06:30:28
Documents
2
Period of Report
2023-11-07

Document Format Files

Seq Description Document Type Size
1 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES form3.html 3  
1 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES form3.xml 3 1558
2 POWER OF ATTORNEY exhibit24.txt EX-24 1771
  Complete submission text file 0001062993-23-020477.txt   4772
Mailing Address 12 GILL STREET SUITE 4650 WOBURN MA 01801
Business Address 12 GILL STREET SUITE 4650 WOBURN MA 01801 (617)871-2101
Comera Life Sciences Holdings, Inc. (Issuer) CIK: 0001907685 (see all company filings)

IRS No.: 874706968 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ETERNA THERAPEUTICS INC. 1035 CAMBRIDGE STREET, STE. 18A CAMBRIDGE MA 02141
Business Address
Clarke Dorothy J (Reporting) CIK: 0001992152 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-41403 | Film No.: 231394875